Reducing social disparities in cancer risk

描述（由申请人提供）： Glorian Sorensen博士是哈佛公共卫生学院（HSPH）的社会、人类发展和健康教授，也是Dana-Farber癌症研究所（DFCI）社区研究中心主任。 她的研究的核心是随机工作场所和社区为基础的研究，测试针对个人和组织变革的干预措施的有效性。 她的研究重点特别是设计和测试干预措施，以有效地为低收入，多民族人口。 自1986年以来，Sorensen博士一直是12项同行评审研究赠款的主要研究者，其中包括8项NIH资助的R 01和1项P01。 自1992年以来，她已经正式指导了5名博士生，7名博士后研究员和8名初级教师。 索伦森博士现在准备巩固她的研究计划，并扩大她的指导。 她的职业目标是为减少社会阶层和种族/民族的癌症风险差异做出重大贡献。 为了实现这一目标，她已经清楚地描绘了一套研究和指导目标。 对于研究，她的目标是进行严格的，精心设计的研究，旨在：（1）确定与癌症风险差异相关的社会背景因素;（2）将对这些社会背景因素的理解纳入干预设计;（3）测试干预措施的有效性，以减少风险差异;（4）开发和测试有效的策略，以传播基于证据的干预措施。 对于指导，她的目标是为新的科学家（包括初级教师，博士后研究员和博士生）提供指导，以便他们能够为癌症预防和控制做出重大和有意义的贡献，包括减少癌症风险的差异。 此外，她的目标是增加她与少数民族初级研究人员的工作，特别是促进他们参与有色人种社区的癌症预防研究。 K 05将为Sorensen博士提供50%的工作，其中60%将专注于研究，40%用于指导。 DFCI、HSPH和Dana-Farber-哈佛癌症中心为该申请提供了坚实的机构支持，并将为研究和指导提供保护时间。

DESCRIPTION (provided by applicant): Dr. Glorian Sorensen, PhD, MPH, is Professor of Society, Human Development and Health in the Harvard School of Public Health (HSPH) and Director of the Dana-Farber Cancer Institute's (DFCI) Center for Community-Based Research. The core of her research is randomized worksite- and community-based studies that test the effectiveness of interventions targeting individual and organizational change. Her research focuses particularly on designing and testing interventions to be effective for low-income, multiethnic populations. Since 1986, Dr. Sorensen has been the Principal Investigator on 12 peer-reviewed research grants, including eight NIH-funded R01s and one P01. Since 1992, she has formally mentored 5 doctoral students, seven post-doctoral fellows, and eight junior faculty. Dr. Sorensen is now poised to solidify her research program and expand her mentoring. Her career goal is to make significant contributions to reductions in disparities in cancer risk by social class and race/ethnicity. To accomplish this goal, she has clearly delineated a set of research and mentoring objectives. For research, she aims to conduct rigorous, well-designed studies aimed at: (1) identifying social contextual factors associated with disparities in cancer risk; (2) incorporating an understanding these social contextual factors into intervention design; (3) testing the efficacy of interventions to reduce disparities in risk; and (4) developing and testing effective strategies for disseminating evidence-based interventions. For mentoring, she aims to provide mentoring for new scientists (including junior faculty, post-doctoral fellows, and doctoral students), in order that they will be able to make significant and meaningful contributions to cancer prevention and control, including to the reduction in disparities in cancer risk. In addition, she aims to increase her work with minority junior investigators, with the particular aim of promoting their participation in cancer prevention research for communities of color. This K05 will provide for 50% of Dr. Sorensen's effort, 60% of which will be focused on research and 40% on mentoring. The DFCI, HSPH, and Dana-Farber- Harvard Cancer Center have provided solid institutional support for this application, and will provide protected time for research and mentoring.